- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00375856
Computer-Assisted Total Knee Replacement Kinematics: DePuy Sigma Posterior Cruciate Substituting Knee and the DePuy Sigma RP Rotating Platform Knee
September 26, 2016 updated by: Dr. John Rudan, Queen's University
An Investigation of Computer-Assisted Total Knee Replacement Kinematics on Patient Performance: An Examination of the DePuy P.F.C.® SigmaTM Posterior Cruciate Substituting Knee and the DePuy P.F.C.® Sigma RP Rotating Platform Knee Systems
Primary Research Questions:
- Do patients with knee osteoarthritis (OA) who undergo total knee replacement with a Sigma rotating platform have better clinical outcomes at 2 years post surgery (i.e. quality of life, function, range of motion) than similar patients who undergo total knee arthroplasty (TKA) using the Sigma fixed bearing knee?
- Do patients with knee OA who undergo TKA with a Sigma rotating platform have different knee kinetics and kinematics as measured by gait analysis than similar patients who undergo TKA using the Sigma fixed bearing knee?
- Do patients with knee OA who undergo TKA with or without computer assistance have better clinical outcomes at two years following surgery (quality of life, function, range of motion)?
- Do patients with knee OA who undergo TKA with or without computer assistance have different knee kinematics and kinetics as measured by gait analysis?
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
91
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R2K 3S8
- University of Manitoba
-
-
Ontario
-
Kingston, Ontario, Canada
- Kingston General Hospital
-
London, Ontario, Canada, N6A 5A5
- London Health Sciences Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 45-75 years
- Undergoing primary total knee arthroplasty
- Clinically significant osteoarthritic degeneration
Exclusion Criteria:
- Active articular infections
- Bilateral knee replacement (simultaneous)
- Previous joint infections
- Significant concurrent ipsilateral hip osteoarthritis
- Chronic pain syndrome requiring medications for control
- History of chemical addiction
- Significant spinal stenosis, significant symptomatic sciatica
- Patients who are unlikely to comply with, participate in, or return for follow-up visits as described in the protocol
- Osteomyelitis, septicemia or other infections that may spread to other areas of the body
- Highly communicable diseases, immuno-compromising conditions and/or conditions that may limit follow-up (eg. AIDS, active tuberculosis, venereal disease, active hepatitis, neoplastic disease)
- Decreased mental comprehension and literacy
- Prior high tibial osteotomy
- Prior patellectomy
- Rheumatoid arthritis
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: 1
DePuy P.F.C.® SigmaTM Posterior Cruciate Substituting Knee
|
|
EXPERIMENTAL: 2
Rotating Platform Knee
|
no details
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Gait and radiographic parameters
|
Secondary Outcome Measures
Outcome Measure |
---|
Knee pain, function
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: John F Rudan, MD, Queen's University/Kingston General Hospital
- Principal Investigator: Steve MacDonald, MD, London Health Sciences Center
- Principal Investigator: Eric Bohm, MD, University of Manitoba/Concordia Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2006
Primary Completion (ACTUAL)
December 1, 2012
Study Completion (ACTUAL)
December 1, 2012
Study Registration Dates
First Submitted
September 12, 2006
First Submitted That Met QC Criteria
September 12, 2006
First Posted (ESTIMATE)
September 13, 2006
Study Record Updates
Last Update Posted (ESTIMATE)
September 27, 2016
Last Update Submitted That Met QC Criteria
September 26, 2016
Last Verified
May 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DepuyRP06
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
-
Max Biocare Pty. Ltd.Completed
Clinical Trials on DePuy P.F.C.® Sigma Rotating Platform Knee
-
Seoul National University HospitalCompletedOsteoarthritis, KneeKorea, Republic of
-
University of AarhusRegionshospitalet Silkeborg; Gigtforeningen; ProtesekompagnietCompletedOsteoarthritisDenmark
-
DePuy OrthopaedicsCompletedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Juvenile Rheumatoid Arthritis | Post-Traumatic Arthritis | Other Inflammatory ArthritisUnited States
-
DePuy OrthopaedicsCompletedOsteoarthritis | Rheumatoid Arthritis | Post-traumatic Arthritis | Juvenile Rheumatoid Arthritis | Avascular Necrosis of BoneUnited States
-
DePuy OrthopaedicsTerminatedArthritis, Rheumatoid | Osteoarthritis | Rheumatoid Arthritis | Post-traumatic Arthritis | Avascular Necrosis of BoneUnited States
-
Minneapolis Veterans Affairs Medical CenterDepuy, Inc.TerminatedOsteoarthritis, KneeUnited States
-
DePuy InternationalTerminated
-
DePuy InternationalCompletedKnee OsteoarthritisUnited Kingdom, Germany, Italy
-
Isfahan University of Medical SciencesCompletedOsteoarthritisIran, Islamic Republic of
-
DePuy InternationalTerminatedKnee OsteoarthritisUnited Kingdom